NeOnc Technologies Holdings, Inc. (NTHI) News
Track canonical SquawkNews coverage tagged to NTHI, NeOnc Technologies Holdings, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NTHI - Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
NTHI - Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
EQUITY | Aug 12, 2026, 01:38 PM UTC
M
NTHI Trading Resumes
NTHI will resume at 8:30 am
EQUITY | Aug 12, 2026, 12:04 PM UTC
H
NTHI Reports Positive Phase 2a Results
NTHI reports positive topline Phase 2a results for Intranasal NEO100
EQUITY | Aug 12, 2026, 12:00 PM UTC
L
NTHI - NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
NTHI - NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
EQUITY | Jul 27, 2026, 01:00 PM UTC
H
NTHI Gains Momentum
NTHI builds regulatory momentum with 4 new research reports and UAE/Dubai drug approval ahead of Phase 2 data
EQUITY | Jun 24, 2026, 12:45 PM UTC
M
NTHI Receives UAE IND Approval
NeOnc Technologies receives UAE IND approval for NEO100, expanding global development ahead of anticipated Phase 2 data milestone
EQUITY | Jun 23, 2026, 01:01 PM UTC